UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029443
Receipt number R000033631
Scientific Title Assessment of the effect of cognitive behavioral therapy on healthcare movements
Date of disclosure of the study information 2017/10/11
Last modified on 2019/04/07 10:57:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of the effect of cognitive behavioral therapy on healthcare movements

Acronym

CBT on healthcare movements

Scientific Title

Assessment of the effect of cognitive behavioral therapy on healthcare movements

Scientific Title:Acronym

CBT on healthcare movements

Region

Japan


Condition

Condition

Myotonic dystrophy

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Developing a program of cognitive behavioral therapy for patients with myotonic dystrophy to facilitate selfcare movements

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The achievement rate of targeted amount of activities measured by wearable terminals during two months intervention period

Key secondary outcomes

The achievement rate of targeted body weight at the endpoint of intervention period
The before-after analysis in HbA1c
The before-after analysis of neuropsychological test


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Cognitive behavioral therapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients understanding the protocol and giving informed consent
Patients who can stand without any assistances and monitor their body weight

Key exclusion criteria

Patients with dementia and severe comorbidities

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Tsuyoshi
Middle name
Last name Matsumura

Organization

National Hospital Organization Osaka Toneyama Medical Center

Division name

Neurology

Zip code

560-8552

Address

Toneyama 5-1-1, Toyonaka, Osaka

TEL

06-6853-2001

Email

tmatsumura-toneyama@umin.org


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Takehara

Organization

National Hospital Organization Osaka Toneyama Medical Center

Division name

Clinical Research

Zip code

560-8552

Address

Toneyama 5-1-1, Toyonaka, Osaka

TEL

06-6853-2001

Homepage URL

http://www.toneyama-hosp.jp/patient/clinical/index.html

Email

chiken@toneyama.go.jp


Sponsor or person

Institute

National Hospital Organization Osaka Toneyama Medical Center

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Graduate School of Medicine, Osaka University
National Hospital Organization Okinawa National Hospital
Nara University
Faculty of Education, Oita University
Okinawa International University
Grobal Center for Medical Engineering and Informatics, Osaka Univiersity
Graduate School of Medicine, Kyoto University
Yokohama Rosai Hospital
National Hosiptal Organization Suzuka National Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

NHO Osaka Toneyama Medical Center

Address

Toneyama 5-1-1, Toyonaka, Osaka, Japan

Tel

+81668532001

Email

tmatsumura-toneyama@umin.org


Secondary IDs

Secondary IDs

YES

Study ID_1

1724

Org. issuing International ID_1

National Hospital Organization Osaka Toneyama Medical Center

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構大阪刀根山医療センター(大阪府)、大阪大学医学部附属病院(大阪府)、国立病院機構沖縄病院(沖縄県)、国立病院機構鈴鹿病院(三重県)、横浜労災病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

9

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 09 Month 20 Day

Date of IRB

2017 Year 09 Month 20 Day

Anticipated trial start date

2017 Year 10 Month 11 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 05 Day

Last modified on

2019 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033631


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name